RAPT Projected Dividend Yield
RAPT Therapeutics Inc ( NASDAQ : RAPT )RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with needs in inflammatory diseases and oncology. Utilizing its proprietary drug discovery and development engine, Co. is developing selective small molecules designed to modulate the immune responses underlying these diseases. Co.'s main inflammation drug candidate, RPT193, and its main oncology drug candidate, FLX475, each target C-C motif chemokine receptor 4, a drug target that potentially has applicability in inflammatory diseases and oncology. 20 YEAR PERFORMANCE RESULTS |
RAPT Dividend History Detail RAPT Dividend News RAPT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |